Skip to main content
OpenTrials

Clinical trial condition

Prostatic Diseases

Explore clinical trials studying Prostatic Diseases. Study availability and eligibility vary by location and protocol.

5,377 public trials 1,047 recruiting studies
Refine in advanced search Browse all conditions

Prostatic Diseases trial results

Completed

Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022)

NCT01846793

Conditions
BPH, Benign Prostatic Hyperplasia, Female Urogenital Diseases, +18 more
Locations
  • For information concerning this clinical site, please contact Nymox at 800-936-9669. Laguna Beach, California, United States
  • For information concerning this clinical site, please contact Nymox at 800-936-9669. San Diego, California, United States
  • For information concerning this clinical site, please contact Nymox at 800-936-9669. Aventura, Florida, United States
  • For information concerning this clinical site, please contact Nymox at 800-936-9669. Naples, Florida, United States
View all 17 locations
View Trial Details
Completed

Two-Dose Level Evaluation of NX-1207 for the Treatment of Low Risk, Localized (T1c) Prostate Cancer

NCT01620515

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • For information concerning this clinical site, please contact Nymox at 800-936-9669. Tucson, Arizona, United States
  • For information concerning this clinical site, please contact Nymox at 800-936-9669. Atherton, California, United States
  • For information concerning this clinical site, please contact Nymox at 800-936-9669. La Mesa, California, United States
  • For information concerning this clinical site, please contact Nymox at 800-936-9669. Long Beach, California, United States
View all 23 locations
View Trial Details
Completed

Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic Hyperplasia

NCT02106182

Conditions
Benign Prostatic Hyperplasia, Genital Diseases, Genital Diseases, Male, +9 more
Locations
  • Bucheon St.Mary's Hospital Bucheon-si, Gyeonggi-do, South Korea
  • Ajou University Hospital Suwon, Gyeonggi-do, South Korea
  • Pusan Natonal University Hospital Busan, South Korea
  • Eulji University Hospital Daejeon, South Korea
View Trial Details
Completed

Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone Therapy

NCT00172055

Conditions
Bone Diseases, Bone Diseases, Metabolic, Cancer Prostate, +14 more
Locations
  • Novartis Investigative Site Anderlecht, Belgium
  • Novartis Investigative Site Antwerp, Belgium
  • Novartis Investigative Site Bruges, Belgium
  • Novartis Investigative Site Brussels, Belgium
View all 19 locations
View Trial Details
Completed

Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer

NCT01415960

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Genesis Research San Diego, California, United States
  • Atlantic Urological Associates Daytona Beach, Florida, United States
  • Urology Health Team Ocala, Florida, United States
  • Winter Park Urology Associates, PA Orlando, Florida, United States
View all 25 locations
View Trial Details
Completed

Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment

NCT00090103

Conditions
Genital Diseases, Genital Diseases, Male, Male Urogenital Diseases, +3 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Birmingham, Alabama, United States
View all 503 locations
View Trial Details
Completed

Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy

NCT00470834

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • GSK Investigational Site Homewood, Alabama, United States
  • GSK Investigational Site Huntsville, Alabama, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site Anaheim, California, United States
View all 62 locations
View Trial Details

Related conditions